KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of GoodwillCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

International Flavors & Fragrances (IFF) Share-based Compensation (2016 - 2025)

International Flavors & Fragrances (IFF) has 17 years of Share-based Compensation data on record, last reported at $32.0 million in Q2 2025.

  • For Q2 2025, Share-based Compensation rose 28.0% year-over-year to $32.0 million; the TTM value through Jun 2025 reached $85.0 million, up 11.84%, while the annual FY2025 figure was $88.0 million, 14.29% up from the prior year.
  • Share-based Compensation reached $32.0 million in Q2 2025 per IFF's latest filing, up from $19.0 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $32.0 million in Q2 2025 and bottomed at $9.0 million in Q1 2022.
  • Average Share-based Compensation over 5 years is $16.4 million, with a median of $16.0 million recorded in 2021.
  • Peak YoY movement for Share-based Compensation: soared 112.5% in 2021, then fell 29.41% in 2022.
  • A 5-year view of Share-based Compensation shows it stood at $10.0 million in 2021, then grew by 20.0% to $12.0 million in 2022, then grew by 25.0% to $15.0 million in 2023, then grew by 20.0% to $18.0 million in 2024, then surged by 77.78% to $32.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Share-based Compensation were $32.0 million in Q2 2025, $19.0 million in Q1 2025, and $18.0 million in Q4 2024.